The acne medication Clindagel (clindamycin phosphate 1 percent) topical gel is now owned by Onset Dermatologics, according to a news release.
Michelle Sprehe
Advertisement
Articles by Michelle Sprehe
Advertisement
Latest Updated Articles
- Onset acquires rights to acne med Clindagel
November 12th 2013
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen
2
Social Media Mythbusters: Hypochlorous Acid Sprays
3
Quoin Submits First-Ever IND Application for Peeling Skin Syndrome Therapy
4
SkinJect Advances into Registrable Development as Potential First-in-Class Therapy for Gorlin Syndrome
5